Moreover, as we show that SELP mediates the secretion of T cells suppressing cytokines, and that its inhibition facilitates the infiltration of CD8 positive T cells into the tumor, anti-SELP treatment may improve the susceptibility of GB tumors to existing immunotherapies, hence sensitizing this non-responsive tumor to become immune checkpoint therapy (ICT)-responsive. This evidence concerns the gene SELP and neoplasm.